AvantGuard™ is blurring the lines between antibiotics, antiseptics, and disinfectants, creating innovative solutions that manage surfaces, including skin, and provide long-term protection against viruses, bacteria, and fungi/mold. The company’s proprietary combinations of specialty molecules and polymers are customized to provide prolonged antimicrobial efficacy to a wide range of surfaces and materials, a $1B opportunity that is critical to ensuring a healthier and safer world.
Most current antiseptics and disinfectants only offer short time (15 minute) protection against dangerous pathogens, helping to create a $100B healthcare problem in hospital acquired infections, food borne illnesses, and antimicrobial resistance. AvantGuard is leading the development of disruptive, cutting-edge technologies that extend the efficacy of disinfectants and antiseptics to provide safe, long lasting, continuous protection against dangerous pathogens.
$4M raised in Pre-seed and Seed Money
Over $7M in Grant Funding
(NIH, NSF, USDA, U.S. Army, NYS ESD BioDefense Fund)
Only formulation to pass EPA MB40 temporary residual antimicrobial coating test to claim 3 log reduction in pathogens in two hours.
AvantGuard is a Cornell University-based spin out company. Originally founded as Halomine Inc. in 2018, we have been aggressively expanding on that original research and found assistance from world renown universities, programs, incubators, and scientists. In addition to licensing technology from Cornell University, we have also licensed N-halamine technology from Auburn University, where they have been working on N-halamine development for 30 years.
Meet the Team
Edward S. Eveleth
Ted is an experienced entrepreneur who has been CEO, COO, CFO, and Chairman in companies covering a broad range of technologies including medical devices, life science molecular tools, waste heat to energy conversion, new materials, and MEMS devices. Ted received a BA in Economics Phi Beta Kappa in three years from Union College and an MBA from the Johnson School at Cornell University.
Dr. Marc Hein
Marc has a Ph.D. in polymer/organic chemistry from Texas A&M University and 30+ years of experience in new product development and commercialization. Marc has led research groups and business development teams in a range of industries including PVC wire and cable, tier 1 automotive window systems, electronic circuit board laminates, offset printing chemicals, styrenic block copolymers, specialty pine chemicals and sustainable specialty chemicals.
VP of Sales and Marketing
Michael is an experienced entrepreneur with over 40 years of experience holding key leadership positions in U.S. Analytical Instruments, AT&T Capital Corporation, Inficon, Rheodyne, Empire State Health Solutions, and IDEX Health and Science Technologies, managing sales, marketing, and business development efforts in North America, Europe, China, and Japan. Michael received a BS in Chemistry in three years from Union College.
VP of Technical Product Management
Dr. Vikram Kanmukhla
Vikram has a Ph.D. in Chemical engineering from Missouri University of Science and Technology and has more than 15 years of experience in R&D, product development, and product scale up and commercialization in startup environments. He brings a vast knowledge of antimicrobial chemistry and experience integrating antimicrobial additives into a variety of synthetic polymers such as polyester, polypropylene in medical textiles to improve patient outcomes.